Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2026-02-01 @ 10:05 AM
Study NCT ID:
NCT01317966
Status:
WITHDRAWN
Last Update Posted:
2016-04-20
First Post:
2011-03-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
Sponsor:
Ming Hou
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ITP-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None